Ataxia-telangiectasia

Chromosomal Instability and Aging: Basic Science and Clinical Implications

Volumn , Issue , 2003, Pages 263-310

  Meyn, M Stephen ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13944283557     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (323)

1. Battista, J. R., Donnelly, C. E., Ohta, T., and Walker, G. C. The SOS response and induced mutagenesis. Prog. Clin. Biol. Res. 340A:l69-l78, 1990.
2. Louis-Bar, D. Sur un syndrome progressif comprenant des télangiectasies capillaires cutanées et conjonctivales symétriques, a disposition naevode et de troubles cérébelleux. Confin. neurol. (Basel) 4:32-42, 1941.
3. Meyn, M. S. The chromosome instability syndromes: lessons for carcinogenesis. Curr Top Microbiol Immunol 221:71-148, 1997.
4. Sedgwick, R. P. and Boder, E. Ataxia-telangiectasia. In: J. M. B. V. DeJong (ed.), Hereditary Neuropathies and Spinocerebellar Atrophies. Vol. 16. New York: Elsevier, 1991, pp. 347-423.
5. Lewis, R. F., Lederman, H. M., and Crawford, T. O. Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol 46:287-295, 1999.
6. Cabana, M. D., Crawford, T. O., Winkelstein, J. A., Christensen, J. R., and Leder-man, H. M. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 102:98-100, 1998.
7. Lefton-Greif, M. A., Crawford, T. O., Winkelstein, J. A., Loughlin, G. M., Koerner, C. B., Zahurak, M., and Lederman, H. M. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 136:225-231, 2000.
8. Peterson, R. D. A. and Good, R. A. Ataxia-telangiectasia. In: D. Bergsma and R. A. Good (eds.), Birth Defects-Immunologic Deficiency Disease in Man. Vol. 4, New York: National Foundation, March of Dimes, 1968, pp. 370-377.
9. Strober, W., Wochner, R. D., Barlow, M. H., McFarlin, D. E., and Waldmann, T. A. Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest 47:1905-1915, 1968.
10. Sadighi, A. A. A., Humphrey, R. L., Winkelstein, J. A., Loeb, D. M., and Leder-man, H. M. Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients. Medicine (Baltimore) 78:370-381, 1999.
11. Li, A., Huang, Y., and Swift, M. Mutation Types and the Survival of A-T Patients. In: Eighth International Workshop on Ataxia-Telangiectasia, Las Vegas, 1999.
12. Peterson, R. D., Funkhouser, J. D., Tuck-Muller, C. M., and Gatti, R. A. Cancer susceptibility in ataxia-telangiectasia. Leukemia 6(Suppl)l:8-l3, 1992.
13. Morrell, D., Cromartie, E., and Swift, M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77:89-92, 1986.
14. Hecht, F. and Hecht, B. K. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 46:9-19, 1990.
15. Sandoval, C. and Swift, M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 31:491-497, 1998.
16. Taylor, A. M. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer (editorial). Br J Cancer 66:5-9, 1992.
17. Spector, B. D., Filipovick, A. H., III, G. S. P., and Kersey, J. H. Epidemiology of cancer in ataxia-telangiectasia. In: B. A. Bridges and D. G. Harnden (eds.), Ataxia-Telangiectasia. New York: Wiley, 1982, pp. 103-138.
18. Woods, C. G. and Taylor, A. M. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med 82:169-179, 1992.
19. Strich, S. Pathological findings in 3 cases of ataxia-telangiectasia. Acta Neurol Scand 42:354-366, 1963.
20. Aguilar, M. J., Kamoshita, S., Landing, B. H., Boder, E., and Sedgwick, R. P. Pathological observations in ataxia-telangiectasia. A report on 5 cases. J Neuropathol Exp Neurol 27:659-676, 1968.
21. Schalch, D. S., McFarlin, D. E., and Barlow, M. H. An unusual form of diabetes mellitus in ataxia telangiectasia. N Eng J Med 282:1396-1402, 1970.
22. Su, Y. and Swift, M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133:770-778, 2000.
23. Cohen, M. M. and Levy, H. P. Chromosome instability syndromes. Adv Hum Genet 18:43-149, 1989.
24. Kojis, T. L., Gatti, R. A., and Sparkes, R. S. The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 56:143-156, 1991.
25. Aurias, A., Dutrillaux, B., Buriot, D., and Lejeune, J. High frequencies of inversions and translocations of chromosme 7 and 14 in ataxia telangiectasia. Mutat Res 69:369-374, 1980.
26. Bigbee, W. L., Langlois, R. G., Swift, M., and Jensen, R. H. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am J Hum Genet 44:402-408, 1989.
27. Lipkowitz, S., Stern, M. H., and Kirsch, I. R. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J Exp Med 172:409-418, 1990.
28. Kobayashi, Y., Tycko, B., Soreng, A. L., and Sklar, J. Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J Immunol 147:3201-3209, 1991.
29. Lipkowitz, S., Garry, V. F., and Kirsch, I. R. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc Natl Acad Sci USA 89:5301-5305, 1992.
30. Cole, J. and Arlett, C. F. Cloning efficiency and spontaneous mutant frequency in circulating T-lymphocytes in ataxia-telangiectasia patients. Int J Radiat Biol 66:S123-131, 1994.
31. Meyn, M. S. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science 260:1327-1330, 1993.
32. Luo, C. M., Tang, W., Mekeel, K. L., DeFrank, J. S., Anne, P. R., and Powell, S. N. High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines. J Biol Chem 271:4497-4503, 1996.
33. Gotoff, S. P., Amirmokri, E., and Liebner, E. J. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child 114:617-625, 1967.
34. Morgan, J. L., Holcomb, T. M., and Morrissey, R. W. Radiation reaction in ataxia telangiectasia. Am J Dis Child 116:557-558, 1968.
35. Feigin, R. D., Vietti, T. J., Wyatt, R. G., Kaufman, D. G., and C H Smith, J. Ataxia telangiectasia with granulocytopenia. J Pediatr 77:431-438, 1970.
36. Eyre, J. A., Gardner-Medwin, D., and Summerfield, G. P. Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia. Arch Dis Child 63:1079-1080, 1988.
37. Rogers, P. B., Plowman, P. N., Harris, S. J., and Arlett, C. F. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57:143-154, 2000.
38. Cornforth, M. N. and Bedford, J. S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 227:1589-1591, 1985.
39. Pandita, T. K. and Hittelman, W. N. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat Res 130:94-103, 1992.
40. Arlett, C. F., Green, M. H., Priestley, A., Harcourt, S. A., and Mayne, L. V. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int J Radiat Biol 54:911-928, 1988.
41. Cole, J., Arlett, C. F., Green, M. H., Harcourt, S. A., Priestley, A., Henderson, L., Cole, H., James, S. E., and Richmond, F. Comparative human cellular radiosensitivity: II. The survival following gamma-irradiation of unstimulated (G0) T-lym-phocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int J Radiat Biol 54:929-943, 1988.
42. Shiloh, Y., Tabor, E., and Becker, Y. The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatin. Carcinogenesis 3:815-820, 1982.
43. Burger, R. M., Drlica, D., and Birdsall, B. The DNA cleavage of iron bleomycin. J Biol Chem 269:25978-25985, 1994.
44. Nelson, W. G. and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823, 1994.
45. Cappelli, E., Rossi, O., Chessa, L., and Frosina, G. Efficient DNA base excision repair in ataxia telangiectasia cells. Eur J Biochem 267:6883-6887, 2000.
46. Taylor, A. M. R., Harnden, D. G., Arlett, C. F., Harcourt, S. A., Lehmann, A. R., Stevens, S., and Bridges, B. A. Ataxia telangiectasia: a human mutation with abnormal radiation senstivity. Nature 258:427-428, 1975.
47. Lehman, A. R. and Stevens, S. The production and repair of double strand breaks in cells from normal humans and from patients with ataxia telangiectasia. Biochim Biophys Acta 474:49-60, 1977.
48. Muriel, W. J., Lamb, J. R., and Lehmann, A. R. UV mutation spectra in cell lines from patients with Cockayne’s syndrome and ataxia telangiectasia, using the shuttle vector pZ189. Mutat Res 254:119-123, 1991.
49. Eady, J. J., Peacock, J. H., and McMillan, T. J. Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity. Br J Cancer 66:113-118, 1992.
50. Debenham, P. G., Webb, M. B., Stretch, A., and Thacker, J. Examination of vectors with two dominant, selectable genes for DNA repair and mutation studies in mammalian cells. Mutat Res 199:145-158, 1988.
51. Cox, R., Masson, W. K., Debenham, P. G., and Webb, M. B. T. The use of recombinant DNA plasmids for the determination of DNA-repair and recombination in cultured mammalian cells. Br J Cancer 46 (Suppl. VI):67-72, 1984.
52. Li, Y., Carty, M. P., Oakley, G. G., Seidman, M. M., Medvedovic, M., and Dixon, K. Expression of ATM in ataxia telangiectasia fibroblasts rescues defects in DNA double-strand break repair in nuclear extracts. Environ Mol Mutagen 37:128-140, 2001.
53. Blocher, D., Sigut, D., and Hannan, M. A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 60:791-802, 1991.
54. Taylor, A. M. R. Unrepaired DNA strand breaks in irradiated ataxia-telangiectasia lymphocytes suggested from cyctogenetic observations. Mutat Res 50:407-418, 1978.
55. Taylor, A. M., Metcalfe, J. A., and McConville, C. Increased radiosensitivity and the basic defect in ataxia telangiectasia. Int J Radiat Biol 56:677-684, 1989.
56. Pandita, T. K. and Hittelman, W. N. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat Res 131:214-223, 1992.
57. Johnson, R. T., Gotoh, E., Mullinger, A. M., Ryan, A. J., Shiloh, Y., Ziv, Y., and Squires, S. Targeting double-strand breaks to replicating DNA identifies a subpathway of DSB repair that is defective in ataxia-telangiectasia cells. Biochem Biophys Res Commun 261:317-325, 1999.
58. Humar, B., Muller, H., and Scott, R. J. Elevated frequency of p53-independent apoptosis after irradiation increases levels of DNA breaks in ataxia telangiectasia lymphoblasts. Int J Radiat Biol 72:257-269, 1997.
59. Murray, A. W. Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359:599-604, 1992.
60. Hartwell, L. H. and Kastan, M. B. Cell cycle control and cancer. Science 266:1821-1828, 1994.
61. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597, 1992.
62. Painter, R. B. and Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77:7215-7217, 1980.
63. Zambeti-Bosseler, F. and Scott, D. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-ir-radiation. Intl J Radiat Biol 39:547-558, 1980.
64. Rudolph, N. S. and Latt, S. A. Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia. Mutat Res 211:31-41, 1989.
65. Beamish, H. and Lavin, M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol 65:175-184, 1994.
66. Takagi, M., Delia, D., Chessa, L., Iwata, S., Shigeta, T., Kanke, Y., Goi, K., Asada, M., Eguchi, M., Kodama, C., and Mizutani, S. Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. Cancer Res 58: 4923-4929, 1998.
67. Xu, B., Kim, S. T., Lim, D. S., and Kastan, M. B. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22:1049-1059, 2002.
68. Khanna, K. K. and Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8:3307-3312, 1993.
69. Canman, C. E., Wolff, A. C., Chen, C. Y., Fornace, A. J., Jr., and Kastan, M. B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res 54:5054-5058, 1994.
70. Cheng, X., Cheong, N., Wang, Y., and Iliakis, G. Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in aged normal fibroblasts. Radiother Oncol 39:43-52, 1996.
71. Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., and Wang, J. Y. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation (see comments). Nature 387:516-519, 1997.
72. Jung, M., Kondratyev, A., Lee, S. A., Dimtchev, A., and Dritschilo, A. ATM gene product phosphorylates I kappa B-alpha. Cancer Res 57:24-27, 1997.
73. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodin-sky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677, 1998.
74. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679, 1998.
75. Khanna, K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., and Lavin, M. F. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20:398-400, 1998.
76. Lee, S. J., Dimtchev, A., Lavin, M. F., Dritschilo, A., and Jung, M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 17:1821-1826, 1998.
77. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 19:175-178, 1998.
78. Matsuoka, S., Huang, M., and Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893-1897, 1998.
79. Brown, K. D., Lataxes, T. A., Shangary, S., Mannino, J. L., Giardina, J. F., Chen, J., and Baskaran, R. Ionizing radiation exposure results in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated protein-dependent mechanism. J Biol Chem 275:6651-6656., 2000.
80. Sikpi, M. O., Wang, Y., and Mallya, S. M. Heightened induction of c-jun mRNA by PMA, EGF and IL-1 in ataxia telangiectasia lymphoblasts. Int J Radiat Biol 75:893-901, 1999.
81. Yan, J., Khanna, K. K., and Lavin, M. F. Defective radiation signal transduction in ataxia-telangiectasia cells. Int J Radiat Biol 76:1025-1035, 2000.
82. Li, N., Banin, S., Ouyang, H., Li, G. C., Courtois, G., Shiloh, Y., Karin, M., and Rotman, G. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J Biol Chem 276:8898-8903, 2001.
83. Meyn, M. S., Strasfeld, L., and Allen, C. Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol 66:S141-149, 1994.
84. Meyn, M. S. Ataxia-telangiectasia and cellular responses to DNA damage (review). Cancer Res 55:5991-6001, 1995.
85. Fritz, E., Elsea, S. H., Patel, P. I., and Meyn, M. S. Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiec-tasia phenotype. Proc Natl Acad Sci USA 94:4538-4542, 1997.
86. Ramsay, J., Birrell, G., Baumann, K., Bodero, A., Parsons, P., and Lavin, M. Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia. Br J Cancer 77:11-14, 1998.
87. Jung, M., Zhang, Y., Dimtchev, A., and Dritschilo, A. Impaired regulation of nuclear factor-kappaB results in apoptosis induced by gamma radiation. Radiat Res 149:596-601, 1998.
88. Liao, W. C., Haimovitz-Friedman, A., Persaud, R. S., McLoughlin, M., Ehleiter, D., Zhang, N., Gatei, M., Lavin, M., Kolesnick, R., and Fuks, Z. Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J Biol Chem 274:17908-17917, 1999.
89. Pernin, D., Bay, J. O., Uhrhammer, N., and Bignon, Y. J. ATM heterozygote cells exhibit intermediate levels of apoptosis in response to streptonigrin and etoposide. Eur J Cancer 35:1130-1135, 1999.
90. Takao, N., Li, Y., and Yamamoto, K. Protective roles for ATM in cellular response to oxidative stress. FEBS Lett 472:133-136, 2000.
91. Shi, Y. Q., Li, L., Sanal, O., Tezcan, I., Emery, G. C., Blattmann, H., and Crompton, N. E. High levels of delayed radiation-induced apoptosis observed in lym-phoblastoid cell lines from ataxia-telangiectasia patients. Int J Radiat Oncol Biol Phys 49:555-559, 2001.
92. Zhang, Y., Dimtchev, A., Dritschilo, A., and Jung, M. Ionizing radiation-induced apoptosis in ataxia-telangiectasia fibroblasts. Roles of caspase-9 and cellular inhibitor of apoptosis protein-1. J Biol Chem 276:28842-28848, 2001.
93. Hotti, A., Jarvinen, K., Siivola, P., and Holtta, E. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases. Oncogene 19:2354-2362, 2000.
94. Tong, X., Liu, B., Dong, Y., and Sun, Z. Cleavage of ATM during radiation-induced apoptosis: caspase-3-like apoptotic protease as a candidate. Int J Radiat Biol 76:1387-1395, 2000.
95. Smith, G. C., di Fagagna, F., Lakin, N. D., and Jackson, S. P. Cleavage and inactivation of ATM during apoptosis. Mol Cell Biol 19:6076-6084, 1999.
96. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma (see comments). Genes Dev 10:2411-2422, 1996.
97. Barlow, C., Liyanage, M., Moens, P. B., Deng, C. X., Ried, T., and Wynshaw-Boris, A. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat Genet 17:462-466, 1997.
98. Wang, Y. A., Elson, A., and Leder, P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci USA 94:14590-14595, 1997.
99. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw-Boris, A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171, 1996.
100. Xu, Y. and Baltimore, D. Dual roles of ATM in the cellular response to radiation and in cell growth control (see comments). Genes Dev 10:2401-2410, 1996.
101. Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., and Leder, P. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 16:397-401, 1997.
102. Herzog, K. H., Chong, M. J., Kapsetaki, M., Morgan, J. I., and McKinnon, P. J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089-1091, 1998.
103. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325, 1999.
104. Bebb, D. G., Warrington, P. J., de, J. G., Yu, Z., Moffat, J. A., Skov, K., Spacey, S., Gelmon, K., and Glickman, B. W. Radiation induced apoptosis in ataxia telangiectasia homozygote, heterozygote and normal cells. Mutat Res 476:13-20, 2001.
105. Meijer, A. E., Zhivotovsky, B., and Lewensohn, R. Epstein-Barr virus-transformed lymphoblastoid cell lines of ataxia telangiectasia patients are defective in X-ray-induced apoptosis. Int J Radiat Biol 75:709-716, 1999.
106. Vaziri, H., West, M. D., Allsopp, R. C., Davison, T. S., Wu, Y. S., Arrowsmith, C. H., Poirier, G. G., and Benchimol, S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16:6018-6033, 1997.
107. Pfeiffer, R. A. Chromosomal abnormalities in ataxia-telangiectasia (Louis Bar’s syndrome). Humangenetik 8:302-306, 1970.
108. Hayashi, K. and Schmid, W. Tandem duplication of q14 and dicentric formation by end-to-end chromosome fusion in ataxia telangiectasia. Humangenetik 30:135-141, 1975.
109. Taylor, A. M. R., Oxford, J. M., and Metcalfe, J. A. Spontaneous cytogenetic abnormalities in lymphocytes from thirteen patients with ataxia telangiectasia. Int J Cancer 27:311-319, 1981.
110. Smilenov, L. B., Morgan, S. E., Mellado, W., Sawant, S. G., Kastan, M. B., and Pan-dita, T. K. Influence of ATM function on telomere metabolism. Oncogene 15:2659-2665, 1997.
111. Metcalfe, J. A., Parkhill, J., Campbell, L., Stacey, M., Biggs, P., Byrd, P. J., and Taylor, A. M. Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 13:350-353, 1996.
112. Pandita, T. K., Pathak, S., and Geard, C. R. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet Cell Genet 71:86-93, 1995.
113. Hande, M. P., Balajee, A. S., Tchirkov, A., Wynshaw-Boris, A., and Lansdorp, P. M. Extra-chromosomal telomeric DNA in cells from Atm(—/—) mice and patients with ataxia-telangiectasia. Hum Mol Genet 10:519-528, 2001.
114. Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaier, B., and Petes, T. D. TEL1, a gene involved in controlling telomere length in S. Cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82:823-829, 1995.
115. Fritz, E., Friedl, A. A., Zwacka, R. M., Eckardt-Schupp, F., and Meyn, M. S. The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells. Mol Biol Cell 11:2605-2616, 2000.
116. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., and et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase (see comments). Science 268:1749-1753, 1995.
117. + gene of Schizosac-charomyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc Natl Acad Sci USA 89:4952-4956, 1992.
118. Weinert, T. A., Kiser, G. L., and Hartwell, L. H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev 8:652-665, 1994.
119. Hari, K. L., Santerre, A., Sekelsky, J. J., McKim, K. S., Boyd, J. B., and Hawley, R. S. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 82:815-821, 1995.
120. Phipps, J., Nasim, A., and Miller, D. R. Recovery, repair, and mutagenesis in Schizosaccharomyces pombe. Adv. Genet. 23:1-72, 1985.
121. Hofmann, A. F. and Harris, S. D. The Aspergillus nidulans uvsB gene encodes an ATM-related kinase required for multiple facets of the DNA damage response. Genetics 154:1577-1586., 2000.
122. Garcia, V., Salanoubat, M., Choisne, N., and Tissier, A. An ATM homologue from Arabidopsis thaliana: complete genomic organisation and expression analysis. Nucleic Acids Res 28:1692-1699., 2000.
123. Jaspers, N. G., Gatti, R. A., Baan, C., Linssen, P. C., and Bootsma, D. Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet 49:0, 1988.
124. Gilad, S., Chessa, L., Khosravi, R., Russell, P., Galanty, Y., Piane, M., Gatti, R. A., Jorgensen, T. J., Shiloh, Y., and Bar-Shira, A. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 62:551-561, 1998.
125. Kraakman-van, d. Z. M., Overkamp, W. J., Jaspers, N. G., Natarajan, A. T., Lohman, P. H., and Zdzienicka, M. Z. Complementation of chromosomal aberrations in AT/NBS hybrids: inadequacy of RDS as an endpoint in complementation studies with immortal NBS cells. Mutat Res 485:177-185, 2001.
126. Gilad, S., Bar-Shira, A., Harnik, R., Shkedy, D., Ziv, Y., Khosravi, R., Brown, K., Vanagaite, L., Xu, G., Frydman, M., Lavin, M. F., Hill, D., Tagle, D. A., and Shiloh, Y. Ataxia-telangiectasia: founder effect among north African Jews. Hum Mol Genet 5:2033-2037, 1996.
127. Telatar, M., Teraoka, S., Wang, Z., Chun, H. H., Liang, T., Castellvi-Bel, S., Udar, N., Borresen-Dale, A. L., Chessa, L., Bernatowska-Matuszkiewicz, E., Porras, O., Watanabe, M., Junker, A., Concannon, P., and Gatti, R. A. Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62:86-97, 1998.
128. Chen, G. and Lee, E. The product of the ATM gene is a 370-kDa nuclear phospho-protein. J Biol Chem 271:33693-33697, 1996.
129. Brown, K. D., Ziv, Y., Sadanandan, S. N., Chessa, L., Collins, F. S., Shiloh, Y., and Tagle, D. A. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci USA 94:1840-1845, 1997.
130. Watters, D., Khanna, K. K., Beamish, H., Birrell, G., Spring, K., Kedar, P., Gatei, M., Stenzel, D., Hobson, K., Kozlov, S., Zhang, N., Farrell, A., Ramsay, J., Gatti, R., and Lavin, M. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14:1911-1921, 1997.
131. Oka, A. and Takashima, S. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci Lett 252:195-198, 1998.
132. Soares, H. D., Morgan, J. I., and McKinnon, P. J. Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telang-iectasia. Neuroscience 86:1045-1054, 1998.
133. Barlow, C., Ribaut-Barassin, C., Zwingman, T. A., Pope, A. J., Brown, K. D., Owens, J. W., Larson, D., Harrington, E. A., Haeberle, A. M., Mariani, J., Eckhaus, M., Herrup, K., Bailly, Y., and Wynshaw-Boris, A. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci USA 97:871-876., 2000.
134. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., and Qin, J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939., 2000.
135. Keegan, K. S., Holtzman, D. A., Plug, A. W., Christenson, E. R., Brainerd, E. E., Flaggs, G., Bentley, N. J., Taylor, E. M., Meyn, M. S., Moss, S. B., Carr, A. M., Ashley, T., and Hoekstra, M. F. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes (see comments). Genes Dev 10:2423-2437, 1996.
136. Suzuki, K., Kodama, S., and Watanabe, M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J Biol Chem 274:25571-25575, 1999.
137. Smith, G. C., Cary, R. B., Lakin, N. D., Hann, B. C., Teo, S. H., Chen, D. J., and Jackson, S. P. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci USA 96:11134-11139, 1999.
138. Kim, S. T., Lim, D. S., Canman, C. E., and Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274:37538-37543, 1999.
139. O’Neill, T., Dwyer, A. J., Ziv, Y., Chan, D. W., Lees-Miller, S. P., Abraham, R. H., Lai, J. H., Hill, D., Shiloh, Y., Cantley, L. C., and Rathbun, G. A. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 275:22719-22727, 2000.
140. Chan, D. W., Son, S. C., Block, W., Ye, R., Khanna, K. K., Wold, M. S., Douglas, P., Goodarzi, A. A., Pelley, J., Taya, Y., Lavin, M. F., and Lees-Miller, S. P. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase. J Biol Chem 275:7803-7810, 2000.
141. Pandita, T. K., Lieberman, H. B., Lim, D. S., Dhar, S., Zheng, W., Taya, Y., and Kastan, M. B. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 19:1386-1391, 2000.
142. Hirai, Y., Hayashi, T., Kubo, Y., Hoki, Y., Arita, I., Tatsumi, K., and Seyama, T. X-irradiation induces up-regulation of ATM gene expression in wild-type lym-phoblastoid cell lines, but not in their heterozygous or homozygous ataxia-telang-iectasia counterparts. Jpn J Cancer Res 92:710-717, 2001.
143. Fang, Z. M., Lee, C. S., Sarris, M., Kearsley, J. H., Murrell, D., Lavin, M. F., Keating, K., and Clarke, R. A. Rapid radiation-induction of ATM protein levels in situ. Pathology 33:30-36, 2001.
144. Lakin, N. D., Weber, P., Stankovic, T., Rottinghaus, S. T., Taylor, A. M., and Jackson, S. P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13:2707-2716, 1996.
145. Andegeko, Y., Moyal, L., Mittelman, L., Tsarfaty, I., Shiloh, Y., and Rotman, G. Nuclear retention of ATM at sites of DNA double strand breaks. J Biol Chem 276:38224-38230, 2001.
146. Perkins, E. J., Nair, A., Cowley, D. O., Van, D. T., Chang, Y., and Ramsden, D. A. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev 16:159-164, 2002.
147. Meyn, M. S. unpublished observations, 2002.
148. Elson, A., Wang, Y., Daugherty, C. J., Morton, C. C., Zhou, F., Campos-Torres, J., and Leder, P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci USA 93:13084-13089, 1996.
149. Kuljis, R. O., Xu, Y., Aguila, M. C., and Baltimore, D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc Natl Acad Sci USA 94:12688-12693, 1997.
150. Borghesani, P. R., Alt, F. W., Bottaro, A., Davidson, L., Aksoy, S., Rathbun, G. A., Roberts, T. M., Swat, W., Segal, R. A., and Gu, Y. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc Natl Acad Sci USA 97:3336-3341, 2000.
151. Eilam, R., Peter, Y., Elson, A., Rotman, G., Shiloh, Y., Groner, Y., and Segal, M. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc Natl Acad Sci USA 95:12653-12656, 1998.
152. Chiesa, N., Barlow, C., Wynshaw-Boris, A., Strata, P., and Tempia, F. Atm-deficient mice Purkinje cells show age-dependent defects in calcium spike bursts and calcium currents. Neuroscience 96:575-583, 2000.
153. Liao, M. J. and Van Dyke, T. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes Dev 13:1246-1250, 1999.
154. Petiniot, L. K., Weaver, Z., Barlow, C., Shen, R., Eckhaus, M., Steinberg, S. M., Ried, T., Wynshaw-Boris, A., and Hodes, R. J. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice. Proc Natl Acad Sci USA 97:6664-6669, 2000.
155. Meyn, M. S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 55:5991-6001, 1995.
156. Morgan, S. E. and Kastan, M. B. p53 and ATM: cell cycle, cell death, and cancer (review). Adv Cancer Res 71:1-25, 1997.
157. Lavin, M. F. and Shiloh, Y. The genetic defect in ataxia-telangiectasia (review). Annu Rev Immunol 15:177-202, 1997.
158. Jeggo, P. A., Carr, A. M., and Lehmann, A. R. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia (review). Trends Genet 14:312-316, 1998.
159. Shiloh, Y. and Kastan, M. B. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 83:209-254, 2001.
160. Khanna, K. K. and Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247-254, 2001.
161. Heddle, J. A., Krepinsky, A. B., and Marshall, R. R. Cellular sensitivity to mutagens and carcinogens in the chromosome-breakage and other cancer-prone syndromes. In: J. German (ed.). Chromosome Mutation and Neoplasia. New York: Liss, 1983, pp. 203-234.
162. Plug, A. W., Peters, A. H., Keegan, K. S., Hoekstra, M. F., de Boer, P., and Ashley, T. Changes in protein composition of meiotic nodules during mammalian meiosis. J Cell Sci 111:413-423, 1998.
163. Dong, Z., Zhong, Q., and Chen, P. L. The Nijmegen breakage syndrome protein is essential for Mre11 phosphorylation upon DNA damage. J Biol Chem 274:1951319516, 1999.
164. Buscemi, G., Savio, C., Zannini, L., Micciche, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., Chen, P., Concannon, P., Chessa, L., and Delia, D. Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 21:5214-5222, 2001.
165. Yazdi, P. T., Wang, Y., Zhao, S., Patel, N., Lee, E. Y., and Qin, J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 16:571-582, 2002.
166. Rogakou, E. P., Boon, C., Redon, C., and Bonner, W. M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146:905-916, 1999.
167. vbNelms, B. E., Maser, R. S., MacKay, J. F., Lagally, M. G., and Petrini, J. H. In situ visualization of DNA double-strand break repair in human fibroblasts. Science 280:590-592, 1998.
168. Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G., Raams, A., Byrd, P. J., Petrini, J. H., and Taylor, A. M. The DNA doublestrand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99:577-587, 1999.
169. Michelson, R. J. and Weinert, T. Closing the gaps among a web of DNA repair disorders. Bioessays 22:966-969, 2000.
170. Bao, S., Tibbetts, R. S., Brumbaugh, K. M., Fang, Y., Richardson, D. A., Ali, A., Chen, S. M., Abraham, R. T., and Wang, X. F. ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature 411:969-974, 2001.
171. Post, S., Weng, Y. C., Cimprich, K., Chen, L. B., Xu, Y., and Lee, E. Y. Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage. Proc Natl Acad Sci USA 98:13102-13107, 2001.
172. Chen, M. J., Lin, Y. T., Lieberman, H. B., Chen, G., and Lee, E. Y. ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J Biol Chem 276:16580-16586, 2001.
173. Falck, J., Petrini, J. H., Williams, B. R., Lukas, J., and Bartek, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 30:290-294, 2002.
174. Taylor, W. R. and Stark, G. R. Regulation of the G2/M transition by p53. Oncogene 20:1803-1815, 2001.
175. Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., and Brody, L. C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30:285-289, 2002.
176. Bischof, O., Kim, S. H., Irving, J., Beresten, S., Ellis, N. A., and Campisi, J. Regulation and localization of the Bloom syndrome protein in response to DNA damage. J. Cell Biol 153:367-380, 2001.
177. Maser, R. S., Monsen, K. J., Nelms, B. E., and Petrini, J. H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol 17:6087-6096, 1997.
178. Gatei, M., Young, D., Cerosaletti, K. M., Desai-Mehta, A., Spring, K., Kozlov, S., Lavin, M. F., Gatti, R. A., Concannon, P., and Khanna, K. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet 25:115-119, 2000.
179. Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., and Chen, D. J. ATM phospho-rylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276:42462-42467, 2001.
180. Ward, I. M., Wu, X., and Chen, J. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J Biol Chem 276:47755-47758, 2001.
181. Yamane, K., Wu, X., and Chen, J. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Mol Cell Biol 22:555-566, 2002.
182. Gatei, M., Zhou, B. B., Hobson, K., Scott, S., Young, D., and Khanna, K. K. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem 276:17276-17280, 2001.
183. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275, 1997.
184. Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., Jr., and Harris, C. C. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 96:3706-3711, 1999.
185. Liao, M. J., Yin, C., Barlow, C., Wynshaw-Boris, A., and van Dyke, T. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction. Mol Cell Biol 19:3095-3102, 1999.
186. Xu, B., Kim, S., and Kastan, M. B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 21:3445-3450, 2001.
187. Rotman, G. and Shiloh, Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress (review). Cancer Surv 29:285-304, 1997.
188. Lim, D. S., Kirsch, D. G., Canman, C. E., Ahn, J. H., Ziv, Y., Newman, L. S., Darnell, R. B., Shiloh, Y., and Kastan, M. B. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95:10146-10151, 1998.
189. Plug, A. W., Peters, A. H., Xu, Y., Keegan, K. S., Hoekstra, M. F., Baltimore, D., de Boer, P., and Ashley, T. ATM and RPA in meiotic chromosome synapsis and recombination. Nat Genet 17:457-461, 1997.
190. Gatti, R. A., Tward, A., and Concannon, P. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 68:419-423, 1999.
191. Spacey, S. D., Gatti, R. A., and Bebb, G. The molecular basis and clinical management of ataxia telangiectasia. Can J Neurol Sci 27:184-191, 2000.
192. Vinters, R. A., Gatti, R. A., and Rakic, P. Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. In: R. A. Gatti and M. Swift (eds.). Ataxia-Telangiectasia: Genetrics, Neuropathology, and Immunology of a Degenerative Disease of Childhood. New York: Liss, 1985, pp. 233-255.
193. Boder, E. and Sedgwick, R. P. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526-554, 1958.
194. Agamanolis, D. P. and Greenstein, J. I. Ataxia-telangiectasia: Report of a case with Lewy bodies and vascular abnormalities within cerebral tissue. J Neuropathol Exp Neurol 39:475-489, 1979.
195. Amromin, G. D., Boder, E., and Teplitz, R. Ataxia-telangiectasia with a 32 year survival. A clinicopathological report. J Neuropathol 38:621-643, 1979.
196. Quick, K. L. and Dugan, L. L. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann Neurol 49:627-635, 2001.
197. Kamsler, A., Daily, D., Hochman, A., Stern, N., Shiloh, Y., Rotman, G., and Barzi-lai, A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61:1849-1854, 2001.
198. Stern, N., Hochman, A., Zemach, N., Weizman, N., Hammel, I., Shiloh, Y., Rotman, G., and Barzilai, A. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 277:602-608, 2002.
199. Yang, Y., Geldmacher, D. S., and Herrup, K. DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci 21:2661-2668, 2001.
200. van der Burgt, I., Chrzanowska, K. H., Smeets, D., and Weemaes, C. Nijmegen breakage syndrome (review). J Med Genet 33:153-156, 1996.
201. Miller, C. W., Ikezoe, T., Krug, U., Hofmann, W. K., Tavor, S., Vegesna, V., Tsukasaki, K., Takeuchi, S., and Koeffler, H. P. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors. Genes Chromosomes Cancer 33:17-21, 2002.
202. Varley, J. M., Evans, D. G., and Birch, J. M. Li-Fraumeni syndrome-a molecular and clinical review. Br J Cancer 76:1-14, 1997.
203. Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., Birch, J. M., Li, F. P., Garber, J., and Haber, D. A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528-2531, 1999.
204. Giannini, G., Ristori, E., Cerignoli, F., Rinaldi, C., Zani, M., Viel, A., Ottini, L., Crescenzi, M., Martinotti, S., Bignami, M., Frati, L., Screpanti, I., and Gulino, A. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 248-254, 2002.
205. Group, I. N. B. S. S. Nijmegen breakage syndrome: The International Nijmegen Breakage Syndrome Study Group. Arch Dis Child 82:400-406, 2000.
206. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182, 2002.
207. Athma, P., Rappaport, R., and Swift, M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cyto-genet 92:130-134, 1996.
208. Welcsh, P. L., Owens, K. N., and King, M.-C. Insights into the functions of BRCA1 and BRCA2. Trends Genet 16:69-68, 2000.
209. FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., and Haber, D. A. Heterozygous ATM mutations do not contribute to early onset of breast cancer (see comments). Nat Genet 15:307-310, 1997.
210. Chen, J., Birkholtz, G. G., Lindblom, P., Rubio, C., and Lindblom, A. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58:1376-1379, 1998.
211. Reed, W. B., Epstein, W. L., Boder, E., and Sedgwick, R. Cutaneous manifestations of ataxia-telangiectasia. JAMA 195:746-753, 1966.
212. Swift, M., Sholman, L., Perry, M., and Chase, C. Malignant neoplasms inthe families of patients with ataxia-telangiectasia. Cancer Res 35:208-215, 1976.
213. Swift, M., Reitnauer, P. J., Morrell, D., and Chase, C. L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294, 1987.
214. Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia (see comments). N Engl J Med 325:1831-1836, 1991.
215. Pippard, E. C., Hall, A. J., Barker, D. J., and Bridges, B. A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2932, 1988.
216. Borresen, A. L., Andersen, T. I., Tretli, S., Heiberg, A., and Moller, P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2:339-340, 1990.
217. Inskip, H. M., Kinlen, L. J., Taylor, A. M., Woods, C. G., and Arlett, C. F. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 79:1304-1307, 1999.
218. Olsen, J. H., Hahnemann, J. M., Borresen-Dale, A. L., Brondum-Nielsen, K., Ham-marstrom, L., Kleinerman, R., Kaariainen, H., Lonnqvist, T., Sankila, R., Seer-sholm, N., Tretli, S., Yuen, J., Boice, J. D., Jr., and Tucker, M. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 93:121-127, 2001.
219. Easton, D. F. Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:S177-182, 1994.
220. Janin, N., Andrieu, N., Ossian, K., Lauge, A., Croquette, M. F., Griscelli, C., Debre, M., Bressac-de-Paillerets, B., Aurias, A., and Stoppa-Lyonnet, D. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 80:1042-1045, 1999.
221. Geoffroy-Perez, B., Janin, N., Ossian, K., Lauge, A., Croquette, M. F., Griscelli, C., Debre, M., Bressac-de-Paillerets, B., Aurias, A., Stoppa-Lyonnet, D., and Andrieu, N. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93:288-293, 2001.
222. Wooster, R., Ford, D., Mangion, J., Ponder, B. A., Peto, J., Easton, D. F., and Stratton, M. R. Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum Genet 92:91-94, 1993.
223. Cortessis, V., Ingles, S., Millikan, R., Diep, A., Gatti, R. A., Richardson, L., Thompson, W. D., Paganini-Hill, A., Sparkes, R. S., and Haile, R. W. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer. Cancer Res 53:5083-5086, 1993.
224. Easton, D. F. The inherited component of cancer. Br Med Bull 50:527-535, 1994.
225. Broeks, A., Urbanus, J. H., Floore, A. N., Dahler, E. C., Klijn, J. G., Rutgers, E. J., Devilee, P., Russell, N. S., van Leeuwen, F. E., and van’t Veer, L. J. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66:494-500, 2000.
226. Laake, K., Vu, P., Andersen, T. I., Erikstein, B., Karesen, R., Lonning, P. E., Skovlund, E., and Borresen-Dale, A. L. Screening breast cancer patients for Norwegian ATM mutations. Br J Cancer 83:1650-1653, 2000.
227. Vorechovsky, I., Rasio, D., Luo, L., Monaco, C., Hammarstrom, L., Webster, A. D., Zaloudik, J., Barbanti-Brodani, G., James, M., Russo, G., and et al. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732, 1996.
228. Izatt, L., Greenman, J., Hodgson, S., Ellis, D., Watts, S., Scott, G., Jacobs, C., Liebmann, R., Zvelebil, M. J., Mathew, C., and Solomon, E. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer 26:286-294, 1999.
229. Bebb, D. G., Yu, Z., Chen, J., Telatar, M., Gelmon, K., Phillips, N., Gatti, R. A., and Glickman, B. W. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer. Br J Cancer 80:1979-1981, 1999.
230. Shafman, T. D., Levitz, S., Nixon, A. J., Gibans, L. A., Nichols, K. E., Bell, D. W., Ishioka, C., Isselbacher, K. J., Gelman, R., Garber, J., Harris, J. R., and Haber, D. A. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer 27:124-129, 2000.
231. Teraoka, S. N., Malone, K. E., Doody, D. R., Suter, N. M., Ostrander, E. A., Daling, J. R., and Concannon, P. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 92:479-487, 2001.
232. Atencio, D. P., Iannuzzi, C. M., Green, S., Stock, R. G., Bernstein, J. L., and Rosenstein, B. S. Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography. Environ Mol Mutagen 38:200-208, 2001.
233. Dork, T., Bendix, R., Bremer, M., Rades, D., Klopper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., Weise, S., Stuhrmann, M., and Karstens, J. H. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 61:7608-7615, 2001.
234. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079, 1991.
235. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194:23-28, 1976.
236. Negrini, M., Rasio, D., Hampton, G. M., Sabbiolni, S., Rattan, S., Carter, S. L., Rosenberg, A. L., Schwartz, G. F., Shiloh, Y., Cavenee, W. K., and Croce, C. M. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Research 55: 3003-3007, 1995.
237. Kerangueven, F., Eisinger, F., Noguchi, T., Allione, F., Wargniez, V., Eng, C., Padberg, G., Theillet, C., Jacquemier, J., Longy, M., Sobol, H., and Birnbaum, D. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339-347, 1997.
238. Laake, K., Odegard, A., Andersen, T. I., Bukholm, I. K., Karesen, R., Nesland, J. M., Ottestad, L., Shiloh, Y., and Borresen-Dale, A. L. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18:175-180, 1997.
239. Rio, P. G., Pernin, D., Bay, J. O., Albuisson, E., Kwiatkowski, F., De Latour, M., Bernard-Gallon, D. J., and Bignon, Y. J. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol 13: 849-853, 1998.
240. Laake, K., Launonen, V., Niederacher, D., Gudlaugsdottir, S., Seitz, S., Rio, P., Champeme, M. H., Bieche, I., Birnbaum, D., White, G., Sztan, M., Sever, N., Plummer, S., Osorio, A., Broeks, A., Huusko, P., Spurr, N., Borg, A., Cleton-Jansen, A. M., van’t Veer, L., Benitez, J., Casey, G., Peterlin, B., Olah, E., Borresen-Dale, A. L., and et al. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. Genes Chromosomes Cancer 25:212-221, 1999.
241. Shen, C. Y., Yu, J. C., Lo, Y. L., Kuo, C. H., Yue, C. T., Jou, Y. S., Huang, C. S., Lung, J. C., and Wu, C. W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 60:3884-3892, 2000.
242. Rodriguez, C., Valles, H., Causse, A., Johannsdottir, V., Eliaou, J. F., and Theillet, C. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases. Genes Chromosomes Cancer 33:141-149, 2002.
243. Waha, A., Sturne, C., Kessler, A., Koch, A., Kreyer, E., Fimmers, R., Wiestler, O. D., von Deimling, A., Krebs, D., and Schmutzler, R. K. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas. Int J Cancer 78:306-309, 1998.
244. Angele, S., Treilleux, I., Taniere, P., Martel-Planche, G., Vuillaume, M., Bailly, C., Bremond, A., Montesano, R., and Hall, J. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res 6:3536-3544, 2000.
245. Kairouz, R., Clarke, R. A., Marr, P. J., Watters, D., Lavin, M. F., Kearsley, J. H., and Lee, C. S. ATM protein synthesis patterns in sporadic breast cancer. Mol Pathol 52:252-256, 1999.
246. Kovalev, S., Mateen, A., Zaika, A. I., O’Hea, B. J., and Moll, U. M. Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines. Int J Oncol 16:825-831, 2000.
247. Finkel, E. Consortium Piecing Together Role of ATM Gene in Breast Cancer. J Natl Cancer Inst 94:158-159, 2002.
248. Vorechovsky, I., Luo, L., Dyer, M. J., Catovsky, D., Amlot, P. L., Yaxley, J. C., Foroni, L., Hammarstrom, L., Webster, A. D., and Yuille, M. A. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17:96-99, 1997.
249. Stilgenbauer, S., Schaffner, C., Litterst, A., Liebisch, P., Gilad, S., Bar-Shira, A., James, M. R., Lichter, P., and Dohner, H. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155-1159, 1997.
250. Stoppa-Lyonnet, D., Soulier, J., Lauge, A., Dastot, H., Garand, R., Sigaux, F., and Stern, M. H. Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91:3920-3926, 1998.
251. Bullrich, F., Rasio, D., Kitada, S., Starostik, P., Kipps, T., Keating, M., Albitar, M., Reed, J. C., and Croce, C. M. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59:24-27, 1999.
252. Stankovic, T., Stewart, G. S., Fegan, C., Biggs, P., Last, J., Byrd, P. J., Keenan, R. D., Moss, P. A., and Taylor, A. M. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 99:300-309, 2002.
253. Stankovic, T., Weber, P., Stewart, G., Bedenham, T., Murray, J., Byrd, P. J., Moss, P. A., and Taylor, A. M. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia (see comments). Lancet 353:26-29, 1999.
254. Schaffner, C., Stilgenbauer, S., Rappold, G. A., Dohner, H., and Lichter, P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94:748-753, 1999.
255. Haidar, M. A., Kantarjian, H., Manshouri, T., Chang, C. Y., O’Brien, S., Freireich, E., Keating, M., and Albitar, M. ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 88:1057-1062, 2000.
256. Cuneo, A., Bigoni, R., Rigolin, G. M., Roberti, M. G., Milani, R., Bardi, A., Minotto, C., Agostini, P., De, A. C., Narducci, M. G., Sabbioni, S., Russo, G., Ne-grini, M., and Castoldi, G. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin’s lymphoma: correlation with clinico-biologic features. J Clin Oncol 18:2607-2614, 2000.
257. Pettitt, A. R., Sherrington, P. D., Stewart, G., Cawley, J. C., Taylor, A. M., and Stankovic, T. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 98:814-822, 2001.
258. Stilgenbauer, S., Winkler, D., Ott, G., Schaffner, C., Leupolt, E., Bentz, M., Moller, P., Muller-Hermelink, H. K., James, M. R., Lichter, P., and Dohner, H. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 94:3262-3264, 1999.
259. Schaffner, C., Idler, I., Stilgenbauer, S., Dohner, H., and Lichter, P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97:2773-2778, 2000.
260. Melo, J. V., Kumberova, A., van, D. A. G., Goldman, J. M., and Yuille, M. R. Investigation on the role of the ATM gene in chronic myeloid leukaemia. Leukemia 15:1448-1450, 2001.
261. Stilgenbauer, S., Schaffner, C., Winkler, D., Ott, G., Leupolt, E., Bentz, M., Moller, P., Muller-Hermelink, H. K., James, M. R., Lichter, P., and Dohner, H. The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol 11(Suppl 1):127-130, 2000.
262. Yuille, M. A., Coignet, L. J., Abraham, S. M., Yaqub, F., Luo, L., Matutes, E., Brito-Babapulle, V., Vorechovsky, I., Dyer, M. J., and Catovsky, D. ATM is usually rearranged in T-cell prolymphocytic leukaemia [published erratum appears in Oncogene 1998 Jun 4;16(22):2955]. Oncogene 16:789-796, 1998.
263. Starostik, P., Manshouri, T., O’Brien, S., Freireich, E., Kantarjian, H., Haidar, M., Lerner, S., Keating, M., and Albitar, M. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 58:4552-4557, 1998.
264. Cuneo, A., Bigoni, R., Rigolin, G. M., Roberti, M. G., Bardi, A., Cavazzini, F., Milani, R., Minotto, C., Tieghi, A., Della, P. M., Agostini, P., Tammiso, E., Negrini, M., and Castoldi, G. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica 87:44-51, 2002.
265. Swift, M., Chase, C. L., and Morrell, D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 46:21-27, 1990.
266. Bevan, S., Catovsky, D., Marossy, A., Matutes, E., Popat, S., Antonovic, P., Bell, A., Berrebi, A., Gaminara, E., Quabeck, K., Ribeiro, I., Mauro, F. R., Stark, P., Sykes, H., van Dongen, J., Wimperis, J., Wright, S., Yuille, M. R., and Houlston, R. S. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia. Leukemia 13:1497-1500, 1999.
267. Iannuzzi, C. M., Atencio, D. P., Green, S., Stock, R. G., and Rosenstein, B. S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52:606-613, 2002.
268. Varghese, S., Schmidt-Ullrich, R. K., Dritschilo, A., and Jung, M. Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient. Radiat Oncol Invest 7:231-237, 1999.
269. Barlow, C., Eckhaus, M. A., Schaffer, A. A., and Wynshaw-Boris, A. Atm haploin-sufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice (letter). Nat Genet 21:359-360, 1999.
270. Smilenov, L. B., Brenner, D. J., and Hall, E. J. Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells. Cancer Res 61:5710-5713, 2001.
271. Weil, M. M., Kittrell, F. S., Yu, Y., McCarthy, M., Zabriskie, R. C., and Ullrich, R. L. Radiation induces genomic instability and mammary ductal dysplasia in Atm heterozygous mice. Oncogene 20:4409-4411, 2001.
272. Becker-Catania, S. G., Chen, G., Hwang, M. J., Wang, Z., Sun, X., Sanal, O., Berna-towska-Matuszkiewicz, E., Chessa, L., Lee, E. Y., and Gatti, R. A. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 70:122-133, 2000.
273. Sandoval, N., Platzer, M., Rosenthal, A., Dork, T., Bendix, R., Skawran, B., Stuhrmann, M., Wegner, R. D., Sperling, K., Banin, S., Shiloh, Y., Baumer, A., Bernthaler, U., Sennefelder, H., Brohm, M., Weber, B. H., and Schindler, D. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8:69-79, 1999.
274. Meyn, M. S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin Genet 55:289-304, 1999.
275. Morgan, S. E., Lovly, C., Pandita, T. K., Shiloh, Y., and Kastan, M. B. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 17:2020-2029, 1997.
276. Scott, S. P., Bendix, R., Chen, P., Clark, R., Dork, T., and Lavin, M. F. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci USA 99:925-930, 2002.
277. Stankovic, T., Kidd, A. M., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A. R., Easton, D. F., Lennox, G. G., Haites, N., Byrd, P. J., and Taylor, A. M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345, 1998.
278. Chenevix-Trench, G., Spurdle, A. B., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M. A., Scott, C., Pupo, G. M., Dork, T., Bendix, R., Kirk, J., Tucker, K., McCredie, M. R., Hopper, J. L., Sambrook, J., Mann, G. J., and Khanna, K. K. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94:205-215, 2002.
279. Werneke, U. Ataxia telangiectasia and risk of breast cancer (letter; comment). Lancet 350:739-740, 1997.
280. Boice, J. D. J. and Miller, R. W. Risk of breast cancer in ataxia-telangiectasia (letter). N Engl J Med 326:1357-1358; discussion 1360-1351, 1992.
281. Gray, J. E. Increased incidence of cancer in a small subset of the population: a new obstacle to screening mammography? (letter). Radiology 185:285, 1992.
282. Kuller, L. H. and Modan, B. Risk of breast cancer in ataxia-telangiectasia (letter). N Engl J Med 326:1357; discussion 1360-1351, 1992.
283. Randal, J. Are mammograms a good idea for AT gene carriers? 87:1351, 1995.
284. Lavin, M. Role of the ataxia-telangiectasia gene (ATM) in breast cancer. A-T heterozygotes seem to have an increased risk but its size is unknown (editorial). BMJ 317:486-487, 1998.
285. Miller, A. B., Howe, G. R., Sherman, G. J., Lindsay, J. P., Yaffe, M. J., Dinner, P. J., Risch, H. A., and Preston, D. L. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321:1285-1289, 1989.
286. Council, N. R. Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academy Press, 1990.
287. Jones, L. A., Scott, D., Cowan, R., and Roberts, S. A. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol 67:519-528, 1995.
288. Norman, A. and Withers, H. R. Mammography screening for A-T heterozygotes. In: R. A. Gatti and R. B. Painter (eds.), Ataxia-Telangiectasia. Vol. H77. Berlin: Springer-Verlag, 1993, pp. 137-140.
289. Rennert, G. The value of mammography in different ethnic groups in Israel-analysis of mortality reduction and costs using CANTrol. Cancer Detect Prev 15: 477-481, 1991.
290. Passarge, E. Bloom’s syndrome: the German experience. Ann Genet 34:179-197, 1991.
291. Loeffler, J. S., Harris, J. R., Dahlberg, W. K., and Little, J. B. In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. Radiat Res 121: 227-231, 1990.
292. Burnet, N. G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J. R., and Peacock, J. H. Prediction of normal-tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. Lancet 339:1590-1571, 1992.
293. Lavin, M. F., Bennett, I., Ramsay, J., Gardiner, R. A., Seymour, G. J., Farrell, A., and Walsh, M. Identification of a potentially radiosensitive subgroup among patients with breast cancer (see comments). J Natl Cancer Inst 86:1627-1634, 1994.
294. Ramsay, J. and Birrell, G. Normal tissue radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 31:339-344, 1995.
295. Appleby, J. M., Barber, J. B., Levine, E., Varley, J. M., Taylor, A. M., Stankovic, T., Heighway, J., Warren, C., and Scott, D. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76:1546-1549, 1997.
296. Ramsay, J., Birrell, G., and Lavin, M. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47:125-128, 1998.
297. Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., Bliss, J. M., Stratton, M. R., and Yarnold, J. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78:922-927, 1998.
298. Xie, S., Wu, H., Wang, Q., Cogswell, J. P., Husain, I., Conn, C., Stambrook, P., Jhanwar-Uniyal, M., and Dai, W. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 276: 43305-43312, 2001.
299. Saito, S., Goodarzi, A. A., Hagashimoto, Y., Noda, Y., Lees-Miller, S. P., Appella, E., and Anderson, C. W. ATM mediates phosphorylation at multiple p53 sites, including Ser46, in response to ionizing radiation. J Biol Chem 277:12491-12494, 2002.
300. Turenne, G. A., Paul, P., Laflair, L., and Price, B. D. Activation of p53 transcriptional activity requires ATM’s kinase domain and multiple N-terminal serine residues of p53. Oncogene 20:5100-5110, 2001.
301. Hirao, A., Kong, Y. Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., and Mak, T. W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827, 2000.
302. Cortez, D., Wang, Y., Qin, J., and Elledge, S. J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks (see comments). Science 286:1162-1166, 1999.
303. Gatei, M., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B., and Khanna, K. K. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res 60:3299-3304, 2000.
304. Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., and Shkedy, D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96:14973-14977, 1999.
305. de, T. S. M., Azzam, E. I., Dahlberg, W. K., Gooding, T. B., and Little, J. B. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-indepen-dent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene 19:6185-6193, 2000.
306. Ahn, J. Y., Schwarz, J. K., Piwnica-Worms, H., and Canman, C. E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 60:5934-5936, 2000.
307. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., and Elledge, S. J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97:10389-10394, 2000.
308. Melchionna, R., Chen, X. B., Blasina, A., and McGowan, C. H. Threonine 68 is required for radiation-induced phosphorylation and activation of cds1. Nat Cell Biol 2:762-765, 2000.
309. Zhao, S., Weng, Y. C., Yuan, S. S., Lin, Y. T., Hsu, H. C., Lin, S. C., Gerbino, E., Song, M. H., Zdzienicka, M. Z., Gatti, R. A., Shay, J. W., Ziv, Y., Shiloh, Y., and Lee, E. Y. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405:473-477, 2000.
310. Lim, D. S., Kim, S. T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H., and Kastan, M. B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613-617, 2000.
311. Li, S., Ting, N. S., Zheng, L., Chen, P. L., Ziv, Y., Shiloh, Y., Lee, E. Y., and Lee, W. H. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406:210-215, 2000.
312. Deng, C. X. and Brodie, S. G. Roles of BRCA1 and its interacting proteins. Bioessays 22:728-737, 2000.
313. Yang, D. Q. and Kastan, M. B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2:893-898, 2000.
314. Kishi, S., Zhou, X. Z., Ziv, Y., Khoo, C., Hill, D. E., Shiloh, Y., and Lu, K. P. Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J Biol Chem 276:29282-29291, 2001.
315. Kim, S. T., Xu, B., and Kastan, M. B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev 16:560-570, 2002.
316. Ababou, M., Dutertre, S., Lecluse, Y., Onclercq, R., Chatton, B., and Amor-Gueret, M. ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. Oncogene 19:5955-5963, 2000 (MEDLINE record in process).
317. Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P. R., Gregory, R. C., Kim, S. T., Lane, W. S., Kastan, M. B., and D’Andrea, A. D. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109:459-472, 2002.
318. Chen, G., Yuan, S. S., Liu, W., Xu, Y., Trujillo, K., Song, B., Cong, F., Goff, S. P., Wu, Y., Arlinghaus, R., Baltimore, D., Gasser, P. J., Park, M. S., Sung, P., and Lee, E. Y. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem 274:12748-12752, 1999.
319. Xia, Z., Morales, J. C., Dunphy, W. G., and Carpenter, P. B. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. J Biol Chem 276:2708-2718, 2001.
320. Wang, X., McGowan, C. H., Zhao, M., He, L., Downey, J. S., Fearns, C., Wang, Y., Huang, S., and Han, J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20:4543-4552, 2000.
321. Lee, S. A., Dritschilo, A., and Jung, M. Role of ATM in oxidative stress-mediated c-Jun phosphorylation in response to ionizing radiation and CdCl2. J Biol Chem 276:11783-11790, 2001.
322. Lin, W. C., Lin, F. T., and Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15:1833-1844, 2001.
323. Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., Scott, G. F., Li, X., Carr, S. A., Johnson, R. K., Winkler, J. D., and Zhou, B. B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18:4047-4054, 1999.